376 related articles for article (PubMed ID: 29075620)
1. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H
Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620
[TBL] [Abstract][Full Text] [Related]
2. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.
Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE
Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470
[TBL] [Abstract][Full Text] [Related]
4. Commentary: The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
Drall KM; Tun HM; Kozyrskyj AL
Front Cell Infect Microbiol; 2018; 8():430. PubMed ID: 30619776
[No Abstract] [Full Text] [Related]
5. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
Takeshima F; Hashiguchi K; Onitsuka Y; Tanigawa K; Minami H; Matsushima K; Akazawa Y; Shiozawa K; Yamaguchi N; Taura N; Ohnita K; Ichikawa T; Isomoto H; Nakao K
Med Sci Monit; 2015 Dec; 21():4111-21. PubMed ID: 26719012
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysis.
Hong AS; Yu WY; Hong JM; Cross CL; Azab M; Ohning G; Jayaraj M
J Gastroenterol Hepatol; 2020 Jun; 35(6):932-940. PubMed ID: 31830335
[TBL] [Abstract][Full Text] [Related]
10. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
[TBL] [Abstract][Full Text] [Related]
11. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
Jonasson C; Tvete IF; Hatlebakk JG
Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
[TBL] [Abstract][Full Text] [Related]
12. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease.
Shi Y; Li J; Cai S; Zhao H; Zhao H; Sun G; Yang Y
Front Cell Infect Microbiol; 2023; 13():1205348. PubMed ID: 37662013
[TBL] [Abstract][Full Text] [Related]
14. Salivary microbiome with gastroesophageal reflux disease and treatment.
Kawar N; Park SG; Schwartz JL; Callahan N; Obrez A; Yang B; Chen Z; Adami GR
Sci Rep; 2021 Jan; 11(1):188. PubMed ID: 33420219
[TBL] [Abstract][Full Text] [Related]
15. Oral microbiome alterations of healthy volunteers with proton pump inhibitor.
Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y
J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152
[TBL] [Abstract][Full Text] [Related]
16. Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months.
Winter H; Gunasekaran T; Tolia V; Gottrand F; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S9-15. PubMed ID: 26121349
[TBL] [Abstract][Full Text] [Related]
17. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
Franke A; Hepp C; Harder H; Beglinger C; Singer MV
Scand J Gastroenterol; 2008; 43(12):1425-31. PubMed ID: 18924018
[TBL] [Abstract][Full Text] [Related]
18. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
Xiao X; Zhang X; Wang J; Liu Y; Yan H; Xing X; Yang J
Gut; 2024 Jun; 73(7):1098-1109. PubMed ID: 38267200
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.
Ward RM; Kearns GL
Paediatr Drugs; 2013 Apr; 15(2):119-31. PubMed ID: 23512128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
